List of Figures:
Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19
Figure 4. Global Rapid Diagnostics Market, 2021-2031, $ mn 22
Figure 5. Impact of COVID-19 on Business 27
Figure 6. Primary Drivers and Impact Factors of Global Rapid Diagnostics Market 29
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 32
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 10. Primary Restraints and Impact Factors of Global Rapid Diagnostics Market 35
Figure 11. Investment Opportunity Analysis 39
Figure 12. Porter’s Fiver Forces Analysis of Global Rapid Diagnostics Market 42
Figure 13. Breakdown of Global Rapid Diagnostics Market by Product, 2021-2031, % of Revenue 47
Figure 14. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 47
Figure 15. Global Rapid Diagnostics Market by Product: Consumables, 2021-2031, $ mn 48
Figure 16. Global Rapid Diagnostics Market by Product: Analyzers/Instruments, 2021-2031, $ mn 49
Figure 17. Breakdown of Global Rapid Diagnostics Market by Prescription, 2021-2031, % of Sales Revenue 51
Figure 18. Global Addressable Market Cap in 2022-2031 by Prescription, Value ($ mn) and Share (%) 51
Figure 19. Global Rapid Diagnostics Market by Prescription: Professional Diagnostics, 2021-2031, $ mn 52
Figure 20. Global Rapid Diagnostics Market by Prescription: OTC Based Testing, 2021-2031, $ mn 53
Figure 21. Breakdown of Global Rapid Diagnostics Market by Platform, 2021-2031, % of Sales Revenue 55
Figure 22. Global Addressable Market Cap in 2022-2031 by Platform, Value ($ mn) and Share (%) 55
Figure 23. Global Rapid Diagnostics Market by Platform: Immunoassays, 2021-2031, $ mn 56
Figure 24. Global Rapid Diagnostics Market by Immunoassays: Lateral Flow Assays, 2021-2031, $ mn 58
Figure 25. Global Rapid Diagnostics Market by Immunoassays: Serological Assays, 2021-2031, $ mn 59
Figure 26. Global Rapid Diagnostics Market by Immunoassays: Other Immunoassays, 2021-2031, $ mn 60
Figure 27. Global Rapid Diagnostics Market by Platform: Molecular Detection, 2021-2031, $ mn 61
Figure 28. Global Rapid Diagnostics Market by Molecular Detection: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 62
Figure 29. Global Rapid Diagnostics Market by Molecular Detection: Other Molecular Detection Tests, 2021-2031, $ mn 63
Figure 30. Global Rapid Diagnostics Market by Platform: Other Platforms, 2021-2031, $ mn 64
Figure 31. Breakdown of Global Rapid Diagnostics Market by Application, 2021-2031, % of Revenue 66
Figure 32. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 66
Figure 33. Global Rapid Diagnostics Market by Application: Blood Glucose Testing, 2021-2031, $ mn 67
Figure 34. Global Rapid Diagnostics Market by Application: Cardiometabolic Testing, 2021-2031, $ mn 68
Figure 35. Global Rapid Diagnostics Market by Application: Infectious Disease Testing, 2021-2031, $ mn 69
Figure 36. Global Rapid Diagnostics Market by Infectious Disease Testing: COVID-19 Testing, 2021-2031, $ mn 71
Figure 37. Global Rapid Diagnostics Market by Infectious Disease Testing: Healthcare-associated Infections (HAI) Testing, 2021-2031, $ mn 72
Figure 38. Global Rapid Diagnostics Market by Infectious Disease Testing: Hepatitis Testing, 2021-2031, $ mn 73
Figure 39. Global Rapid Diagnostics Market by Infectious Disease Testing: Tropical Diseases Testing, 2021-2031, $ mn 74
Figure 40. Global Rapid Diagnostics Market by Infectious Disease Testing: HIV Testing, 2021-2031, $ mn 75
Figure 41. Global Rapid Diagnostics Market by Infectious Disease Testing: Influenza Testing, 2021-2031, $ mn 76
Figure 42. Global Rapid Diagnostics Market by Infectious Disease Testing: Sexually Transmitted Diseases (STD) Testing, 2021-2031, $ mn 77
Figure 43. Global Rapid Diagnostics Market by Infectious Disease Testing: Other Infectious Diseases Testing, 2021-2031, $ mn 78
Figure 44. Global Rapid Diagnostics Market by Application: Blood Coagulation Testing, 2021-2031, $ mn 79
Figure 45. Global Rapid Diagnostics Market by Application: Hematology Testing, 2021-2031, $ mn 80
Figure 46. Global Rapid Diagnostics Market by Application: Cancer Testing, 2021-2031, $ mn 81
Figure 47. Global Rapid Diagnostics Market by Application: Drug Abuse Testing, 2021-2031, $ mn 82
Figure 48. Global Rapid Diagnostics Market by Application: Pregnancy & Fertility Testing, 2021-2031, $ mn 83
Figure 49. Global Rapid Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 84
Figure 50. Breakdown of Global Rapid Diagnostics Market by End User, 2021-2031, % of Revenue 86
Figure 51. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 86
Figure 52. Global Rapid Diagnostics Market by End User: Hospitals & Clinics, 2021-2031, $ mn 87
Figure 53. Global Rapid Diagnostics Market by End User: Laboratories, 2021-2031, $ mn 88
Figure 54. Global Rapid Diagnostics Market by End User: Individuals/Homecare, 2021-2031, $ mn 89
Figure 55. Global Rapid Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 90
Figure 56. Global Market Snapshot by Region 91
Figure 57. Geographic Spread of Worldwide Rapid Diagnostics Market, 2021-2031, % of Sales Revenue 92
Figure 58. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 93
Figure 59. North American Rapid Diagnostics Market, 2021-2031, $ mn 96
Figure 60. Breakdown of North America Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 97
Figure 61. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 98
Figure 62. U.S. Rapid Diagnostics Market, 2021-2031, $ mn 100
Figure 63. Canada Rapid Diagnostics Market, 2021-2031, $ mn 102
Figure 64. Rapid Diagnostics Market in Mexico, 2021-2031, $ mn 104
Figure 65. European Rapid Diagnostics Market, 2021-2031, $ mn 107
Figure 66. Breakdown of European Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 108
Figure 67. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 109
Figure 68. Rapid Diagnostics Market in Germany, 2021-2031, $ mn 110
Figure 69. Rapid Diagnostics Market in U.K., 2021-2031, $ mn 112
Figure 70. Rapid Diagnostics Market in France, 2021-2031, $ mn 114
Figure 71. Rapid Diagnostics Market in Spain, 2021-2031, $ mn 116
Figure 72. Rapid Diagnostics Market in Italy, 2021-2031, $ mn 118
Figure 73. Rapid Diagnostics Market in Netherlands, 2021-2031, $ mn 120
Figure 74. Rapid Diagnostics Market in Rest of Europe, 2021-2031, $ mn 122
Figure 75. Asia-Pacific Rapid Diagnostics Market, 2021-2031, $ mn 125
Figure 76. Breakdown of APAC Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 125
Figure 77. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 127
Figure 78. Rapid Diagnostics Market in Japan, 2021-2031, $ mn 129
Figure 79. Rapid Diagnostics Market in China, 2021-2031, $ mn 131
Figure 80. Rapid Diagnostics Market in Australia, 2021-2031, $ mn 133
Figure 81. Rapid Diagnostics Market in India, 2021-2031, $ mn 135
Figure 82. Rapid Diagnostics Market in South Korea, 2021-2031, $ mn 137
Figure 83. Rapid Diagnostics Market in Rest of APAC, 2021-2031, $ mn 139
Figure 84. South America Rapid Diagnostics Market, 2021-2031, $ mn 142
Figure 85. Breakdown of South America Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 142
Figure 86. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 143
Figure 87. Rapid Diagnostics Market in Argentina, 2021-2031, $ mn 144
Figure 88. Rapid Diagnostics Market in Brazil, 2021-2031, $ mn 146
Figure 89. Rapid Diagnostics Market in Chile, 2021-2031, $ mn 148
Figure 90. Rapid Diagnostics Market in Rest of South America, 2021-2031, $ mn 150
Figure 91. Rapid Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn 152
Figure 92. Breakdown of MEA Rapid Diagnostics Market by Country, 2021 and 2031, % of Revenue 152
Figure 93. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 153
Figure 94. Rapid Diagnostics Market in UAE, 2021-2031, $ mn 154
Figure 95. Rapid Diagnostics Market in Saudi Arabia, 2021-2031, $ mn 156
Figure 96. Rapid Diagnostics Market in South Africa, 2021-2031, $ mn 158
Figure 97. Growth Stage of Global Rapid Diagnostics Industry over the Forecast Period 161
Global Rapid Diagnostics market will reach $ 77,095.6 million by 2031, growing by 7.4% annually over 2021-2031, driven by the growing demand for POC diagnostics, the rising prevalence of chronic diseases coupled with the increasing aging population, the growing necessity for rapid decision making in emergency departments, increase in awareness regarding early diagnosis of disease, and emerging technological innovations. Highlighted with 83 tables and 97 figures, this 183-page report “Global Rapid Diagnostics Market 2021-2031 by Product (Consumables, Analyzers/Instruments), Prescription (Professional, OTC), Platform (Immunoassays, Molecular Detection, Others), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global Rapid Diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global Rapid Diagnostics market in every aspect of the classification from perspectives of Product, Prescription, Platform, Application, End User, and Region. Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Consumables • Analyzers/Instruments Based on Prescription, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Professional Diagnostics • OTC Based Testing By Platform, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Immunoassays o Lateral Flow Assays o Serological Assays o Other Immunoassays • Molecular Detection o Polymerase Chain Reaction (PCR) o Other Molecular Detection Tests • Other Platforms By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood Glucose Testing • Cardiometabolic Testing • Infectious Disease Testing o COVID-19 Testing o Healthcare-associated Infections (HAI) Testing o Hepatitis Testing o Tropical Diseases Testing o HIV Testing o Influenza Testing o Sexually Transmitted Diseases (STD) Testing o Other Infectious Diseases Testing • Blood Coagulation Testing • Hematology Testing • Cancer Testing • Drug Abuse Testing • Pregnancy & Fertility Testing • Other Applications By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals & Clinics • Laboratories • Individuals/Homecare • Other End Users Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE?Saudi Arabia? South Africa and Rest of MEA) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product, Prescription and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Diagnostics ACON Laboratories Becton Dickinson and Co. BioMérieux S.A. Bio-Rad Laboratories, Inc. Chembio Diagnostic Systems Danaher Corp. F. Hoffmann La Roche Ltd. GlySens Inc. Meridian Bioscience Inc. OraSure Technologies Inc. Siemens Healthineers AG Thermo Fisher Scientific Inc. Trinity Biotech Plc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More